GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/Dietary nutrient patterns and the risk of IBS
107

Dietary nutrient patterns and the risk of IBS

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2025

The study investigated the relationship between dietary nutrient patterns and the risk of developing Irritable Bowel Syndrome (IBS) in a diverse Iranian population. Here are the detailed findings and insights:


Study Overview

  • Objective: To determine whether specific nutrient-based dietary patterns are linked to the likelihood of developing IBS.
  • Design: A multicenter case-control study conducted in three provinces of western Iran (Khorramabad, Urmia, and Kermanshah) between 2021 and 2023.
  • Participants:
  • 317 IBS patients (diagnosed using Rome III criteria).
  • 601 healthy controls.
  • Total: 901 participants, with a case-to-control ratio of 1:2.
  • Exclusion Criteria: Chronic diseases, gastrointestinal surgery, pregnancy, smoking, alcohol use, and special diets were excluded to minimize confounding variables.

Dietary Assessment

  • Tool Used: A validated 168-item Food Frequency Questionnaire (FFQ).
  • Data Analysis: Nutrient intake data were analyzed with Nutritionist IV software to calculate macronutrient and micronutrient levels.
  • Nutrient Patterns Identified: Principal Component Analysis (PCA) revealed three major nutrient patterns:
  1. Pattern I: Rich in antioxidants (β-carotene, vitamin C, vitamin A, lutein, vitamin E, etc.).

  2. Pattern II: Rich in maltose, fiber, glucose, and fructose.

  3. Pattern III: High in sugars (sucrose, galactose, lactose) and caffeine.

  • Together, these patterns explained 63.59% of the variance in dietary intake, capturing the primary dietary trends in the study population.

Key Findings

1. Pattern I: Antioxidants

  • Effect on IBS Risk: Higher adherence to this pattern was associated with a 25% reduced odds of IBS (OR = 0.75, CI 0.62–0.92).
  • Implication: Antioxidants, such as carotenoids and vitamins, appear to have protective effects against IBS development.
  • Demographics: Adherence to Pattern I was higher among educated, married, and non-smoking individuals.

2. Pattern II: Fiber and Monosaccharides

  • Effect on IBS Risk: This pattern showed an even stronger protective effect, with a 48% reduced odds of IBS (OR = 0.52, CI 0.42–0.64).
  • Implication: Dietary fiber and fruit-based sugars (e.g., fructose, glucose) may play a significant role in protecting against IBS, despite known issues with fructose malabsorption in some IBS patients.
  • Demographics: Pattern II was more common among physically active individuals.

3. Pattern III: Sugars and Caffeine

  • Effect on IBS Risk: No significant relationship was found between this pattern and IBS risk (OR = 0.95, CI 0.80–1.12).
  • Implication: While sugars and caffeine are often suspected IBS triggers, this study did not find evidence supporting a direct link.
  • Demographics: Pattern III was more common among males and individuals with lower education levels.

Additional Insights

  • Symptom Severity: None of the nutrient patterns were associated with the severity of IBS symptoms. While Patterns I and II reduced the odds of developing IBS, they did not influence how severe the disease was in those who had it.
  • Age and Weight:
  • No significant age differences were observed across Pattern I tertiles.
  • Patterns II and III were associated with higher age.
  • Pattern I was linked to slightly higher weight and BMI.
  • Nutrient Sources: In the Iranian population, fruits were the primary source of fructose and fiber in Pattern II, explaining its protective role despite potential fructose malabsorption in IBS patients.

Context with Other Studies

  • The findings align with prior research suggesting that:
  • Antioxidants, fiber, and phytochemicals promote gut health and reduce IBS risk.
  • However, the study contrasts with some research that implicates caffeine and sugars as IBS risk factors, as no significant relationship was found for Pattern III.

Strengths of the Study

  • Large Sample Size: Inclusion of 901 participants provided robust statistical power.
  • Multicenter Design: Enhanced diversity and generalizability of findings.
  • Adjustment for Confounders: Controlled for factors like age, gender, marital status, energy intake, and physical activity.
  • Focus on Nutrient Patterns: Analyzed dietary patterns rather than individual nutrients, offering a more realistic view of diet complexity.

Clinical Implications

  • Dietary Recommendations for IBS Prevention:
  • Diets rich in antioxidants (e.g., vitamins A, C, E, and carotenoids) may reduce IBS risk.
  • High fiber and fruit-based sugars (e.g., from fruits) are protective and should be encouraged.
  • Sugars and caffeine do not appear to have a significant impact on IBS risk, but individual tolerance should still be considered.
  • These findings can inform guidelines for nutritional strategies targeting IBS prevention.

Conclusion

The study highlights the importance of nutrient-based dietary patterns in IBS risk. Specifically, antioxidant-rich and fiber-rich diets may offer protective benefits, while high sugar and caffeine intake show no clear association. These insights could help shape future dietary recommendations for IBS prevention and management.

Related Q&A

108

12-week low FODMAP diet and levels of GLP-1 in IBS

The study investigated the effects of a 12-week low FODMAP diet (LFD) on GLP-1 (glucagon-like peptide-1) levels in patients with moderate-to-severe irritable bowel syndrome (IBS). Here is a...

109

Factors associated with symptom relief in patients with irritable bowel syndrome

The study identifies several demographic, lifestyle, psychological, and physiological factors associated with symptom relief in patients with irritable bowel syndrome (IBS). Here’s a detailed breakdown of the findings:...

01

Probiotics After Rifaximin May Reduce Relapse in IBS-D: JGH | August 2026

Introduction: Rifaximin can improve symptoms in diarrhoea-predominant irritable bowel syndrome (IBS-D), but relapse after treatment remains common. Because rifaximin alters the intestinal microbial environment, post-treatment microbiome modulation may...

02

Vancomycin Taper vs Fidaxomicin for Recurrent C. difficile Infection (OpTION Trial): NEJM Evidence | August 2026

Introduction: Recurrent Clostridioides difficile infection (CDI) remains a major clinical challenge, with recurrence occurring in up to one-third of patients after initial treatment. Although both vancomycin taper-and-pulse (VAN-TP)...

03

DPP-4 Inhibition targeting the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Increasing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This preclinical study investigated...

04

Adjuvant Aspirin in Colorectal Cancer: The Lancet Gastroenterology & Hepatology | July 2026

Introduction: Although aspirin has long been investigated as adjuvant therapy for colorectal cancer (CRC), the overall ASCOLT trial showed no improvement in disease-free survival (DFS). This translational analysis...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer